Sorry, you need to enable JavaScript to visit this website.

Medical care

Report

2013‐14 Budget: analysis of health and ageing provisions


In a tough political and budget year with several major initiatives to be funded - most notably the Gonski education reforms and the National Disability Insurance Scheme, now known as DisabilityCare Australia - the health and ageing section of the 2013-14 Budget has fared reasonably well. Overall the Budget contained $43 billion in savings over...
Report

Healthy for life - Aboriginal community controlled health services: report card


This report card provides information against Essential Indicators from the HfL Program for Aboriginal Community Controlled Health Services (ACCHS) that have participated in the program since 2007 and the 2010-11 OSR data for ACCHS. In addition, background information on the Indigenous population in general are provided from the 2011 Census preliminary estimates and various AIHW...
Discussion paper

Closing the gap on Indigenous disadvantage: an analysis of provisions in the 2013-14 Budget and implementation of the Indigenous Chronic Disease Package


This paper presents the author’s analysis of the Indigenous provisions in the Australian Government’s 2013-14 Budget in the context of current and past strategies, policies, programs and funding support. It also looks at the implementation and impact of the Commonwealth’s Indigenous Chronic Disease Package. This work has been done using only materials and data that...
Briefing paper

Consumers Health Forum of Australia analysis of the 2013-14 federal budget


This paper argues that the 2013-14 federal budget does not provide relief for consumers struggling with out-of-pocket health costs.
Report

Supply of chemotherapy drugs such as Docetaxel


On 7 February 2013 the Senate referred the following matter to the Senate Community Affairs Committee for inquiry and report: (a) the supply of chemotherapy drugs such as Docetaxel, particularly in relation to: (i) patient access to treatment, (ii) cost to pharmacists and suppliers, and (iii) cost to the private and public hospital systems; (b)...